Physician profile
Michael Joseph Jackson
NPI 1730268046
$9,142.37
in general payments reported to CMS, 2019-2025
51 companies · $674 in 2025
The $674 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $860 · 2020: $717 · 2021: $1,462 · 2022: $3,878 · 2023: $636 · 2024: $915 · 2025: $674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,225.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $2,877.16 | 2021-2022 | |
| Abbvie INC. | $1,418.77 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $486.91 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $385.12 | 2019-2025 | Veozah |
| Myovant Sciences INC. | $383.94 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $341.42 | 2020-2022 | |
| Exeltis, USA INC. | $278.46 | 2021-2025 | Slynd, Solosec |
| Allergan, INC. | $198.59 | 2019-2022 | |
| Therapeuticsmd, INC. | $191.18 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $183.68 | 2019-2020 | |
| Eisai INC. | $162.12 | 2020-2022 | |
| Daiichi Sankyo INC. | $162.08 | 2019-2021 | |
| Lupin INC. | $145.41 | 2019-2021 | |
| Aspira Women'S Health INC | $136.53 | 2022-2024 | Ova1 |
| Mayne Pharma Commercial LLC | $136.06 | 2022-2025 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.